Perspective Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
60%
€14.20
Target price
31.07.27
€20.00
Performance (%)
-76.20%
End price
14.12.24
€3.38
Summary
This prediction ended on 14.12.24 with a price of €3.38. The BUY prediction by BiotechBee for Perspective Therapeutics Inc. performed very badly with a performance of -76.20%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Perspective Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% |
According to BiotechBee what are the pros and cons of Perspective Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Perspective Therapeutics Inc. diskutieren
Buy mit Kursziel 20,0